Chris Bosh's return to the NBA has been a lingering possibility since he found his way out of the Miami Heat organization, who refused to put him back on the court after having suffered continued blood clotting, which was declared a career-ending illness by the league shortly after he was waived by the team.

Many doctors had explained the complications of dealing with Bosh's clots, first suffering from it in one of his lungs in 2015, and another in his leg in 2016, raising some major concern of being a recurring issue.

ESPN Senior Writer Jackie MacMullan appeared on Zach Lowe's podcast and clarified why no team has taken a shot to acquire the 11-time All-Star before the clock runs out in his career.

Article Continues Below

“I’ve been told there’s no hope, and it’s because the situation is too dangerous, too scary,” said MacMullan. “From what I’ve been told, and of course, the records are sealed because of HIPAA laws and because all of his medical records from the Heat have not been seen by other NBA teams, at least that I’m aware of, I should say that, because perhaps someone asked and the Heat obliged, I’m not sure. I didn’t get that sense but I suppose it’s possible. But we don’t really know what else is involved with this. And I get the sense, from talking to GMs around the league, that there’s other things in play here.”

Teams would have to do their due diligence if hoping to acquire Bosh, but as a 33-year-old player who is two seasons removed from playing in the league, it becomes a major shot in the dark for any team willing to roll the dice on his health and the image of their franchise by acquiring someone who is at risk of injuring himself due to a pre-existing condition.